Article · 29 Aug 2026
Conference abstract
Omics guided vaccine development: RandD and industry perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccines are still the most efficient way to cut the health care cost, by simply preventing the occurrence of a disease at population level. However, diseases caused by pathogens such as malaria, influenza and HIV exhibiting highly variant antigen repertoire or high mutation rates still pose a challenge to vaccine development. Omics guided approaches using high throughput technologies (e.g. vaccinomics, genomics and transcriptomics) have enabled us to determine vaccine candidate for these challenging pathogens, however also resulting into massive and complex data. On the other hand, inter-individual variation in vaccine induced immune response is an impending factor to achieve the desired protection at population level. For example, Ovsyannikova and colleagues (2006) at Mayo vaccine research group USA had discovered a measles vaccine candidate by vaccinomics approach. However, they also noticed that genetic heterogeneity among immunized individuals was associated with vaccination failure. Precisely, genetic polymorphisms at HLA, SLAM and CD46 were among top factors found responsible for this effect. Different vaccination strategy could be adopted to improve immunity level in those cases. Similar stories exist for Hepatitis B and other vaccines. Thus, increasing number of analytical variables concerns the vaccine industry at multiple fronts, such as higher vaccine development cost, greater analytical complexity as well as regulatory issues. The discussion will constitute research as well as industry perspective of next generation approaches in vaccine development and associated drivers and challenges.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Ramesh Chandra Pandey”
